Structured facts
{
"code": "A",
"date": "2026-04-13",
"direction": "A",
"exercise_price": null,
"expiration": null,
"footnotes": {
"F1": "On January 31, 2025, the reporting person was granted performance restricted stock units (PSUs) which PSUs vested on April 13, 2026 upon the Issuer\u0027s confirmation that the U.S. Food and Drug Administration (FDA) had granted approval of FILSPARI (sparsentan) in FSGS."
},
"owners": [
{
"cik": "0001698262",
"name": "ROTE WILLIAM E.",
"roles": [
"officer"
],
"title": "Chief Research Officer"
}
],
"ownership": "D",
"post_shares": "123087",
"price": "0",
"row": 1,
"rule_10b5_1": "1",
"security": "Common Stock",
"shares": "14000",
"table": "I",
"underlying_security": null,
"underlying_shares": null
}